Next Article in Journal
Temporal Incidence of Eriophyid Mites on Rose Rosette Disease-Symptomatic and -Asymptomatic Roses in Central Georgia, USA
Next Article in Special Issue
Epidemiology, Clinical Features, and Unusual Complications of Norovirus Infection in Taiwan: What We Know after Rotavirus Vaccines
Previous Article in Journal
Enduring Challenges despite Progress in Preventing Mother-to-Child Transmission of Hepatitis B Virus in Angola
Previous Article in Special Issue
First Detection and Genomic Characterization of Bovine Norovirus from Yak
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Perspective

Illuminating Human Norovirus: A Perspective on Disinfection of Water and Surfaces Using UVC, Norovirus Model Organisms, and Radiation Safety Considerations

Crystal IS Inc., an Asahi Kasei Company, 70 Cohoes Avenue, Green Island, NY 12183, USA
*
Author to whom correspondence should be addressed.
Pathogens 2022, 11(2), 226; https://doi.org/10.3390/pathogens11020226
Submission received: 2 December 2021 / Revised: 22 January 2022 / Accepted: 3 February 2022 / Published: 8 February 2022
(This article belongs to the Special Issue Norovirus and Viral Gastroenteritis)

Abstract

:
Human noroviruses (HuNoVs) are a major cause of gastroenteritis and are associated with high morbidity because of their ability to survive in the environment and small inoculum size required for infection. Norovirus is transmitted through water, food, high touch-surfaces, and human-to-human contact. Ultraviolet Subtype C (UVC) light-emitting diodes (LEDs) can disrupt the norovirus transmission chain for water, food, and surfaces. Here, we illuminate considerations to be adhered to when picking norovirus surrogates for disinfection studies and shine light on effective use of UVC for norovirus infection control in water and air and validation for such systems and explore the blind spot of radiation safety considerations when using UVC disinfection strategies. This perspective also discusses the promise of UVC for norovirus mitigation to save and ease life.

Graphical Abstract

1. Background

Noroviruses (NoVs), belonging to family Caliciviridae, are positive-sense, single-stranded RNA viruses [1]. They are commonly spread through contaminated water and food and are a major cause of diarrheal illness [1,2]. The number of norovirus genogroups has been expanded to 10 (GI through GX) [3], five of which (GI, GII, GIV, GVIII, and GIX) comprise of human noroviruses (HuNoVs) [3]. Each genogroup is further subdivided into genotypes. GII.2 strains (Figure 1) have been reported as dominant isolates in recent outbreaks [4,5,6,7,8,9].
Annually, the global economic burden associated with gastroenteritis due to HuNoV is estimated to be more than USD 60 billion [10]. In the USA, norovirus gastroenteritis caused by HuNoV accounts for an estimated 56,000–71,000 hospitalizations and an average of 570–800 deaths per year [11]. To put it into perspective, in the USA, the HuNoV is associated with 20 times more gastroenteritis cases than any enteric pathogen [12]. Sometimes, the effects of norovirus are overlooked because they are often self-limiting in healthy adults, lasting a couple of days [13]. However, the effects of norovirus can be quite serious in young children, with over a million health care visits annually [14]. Additionally, for the elderly, HuNoV is associated with 20% of gastrointestinal (GI) deaths for those more than 65 years of age [15] as well as the immunocompromised, whose HuNoV infections can last for years [13]. Due to a wide diversity of norovirus genotypes [16], mutations, and the lack of good indicators of immunity, vaccine design, and development has been very difficult [2,17,18]. Therefore, prevention remains the best protection [19]. Still, the genetic, biological, antigenic, and antigen binding diversity, virulence, and stability in the environment of the HuNoVs make prevention difficult even for the developed countries [20,21]. Additional disinfection strategies, such as the use of UVC, will go a long way towards reducing infections and mortalities due to HuNoV.

2. Transmission of HuNoVs

Norovirus [22] is transmitted via surfaces [23], food contaminated by food handlers [24], contaminated vegetables, and undercooked or raw food [25], or water [26]. Person-to-person transmission is also unavoidable once a foodborne infection happens [25]. Transmissivity is high because it only requires a small inoculum size [27,28]. HuNoVs survive in the environment for a long time [27]. Disinfection has been critical to limiting transmission through the application of chlorine or other disinfectants in water [29], hand washing [23], and surface sterilization [23]. However, although norovirus can be transmitted year-round, hospitalizations and deaths peak in late winter and early spring [30]. It mainly spreads through fecal–oral transmission [31], either through person-to-person transmission or contaminated food or water [31]. It can also be transmitted through fomites [31]. Facilities that process food can greatly benefit by incorporating UV light technologies to control microbial transmission and ensure food safety [32,33].

3. HuNoV Control Programs

Norovirus outbreak management and disease prevention strategies are key in the disruption of disease transmission in many setting [27]. This can be in the form of institutional policies and development of effective hygiene programs and disinfection strategies, such as the use of UVC. In healthcare settings, guidelines aimed at preventing and controlling norovirus gastroenteritis outbreaks have been recommended [34]. These recommendations rely on empirical evidence although such evidence is limited by the inability to culture HuNoVs in laboratories [35]. Previously, there have been a few successful norovirus infection control tests in hospital settings [36,37,38]. For environmental health and safety, the current recommendation is physical removal of loose viral particles followed by use of medical grade disinfectants, especially ethanol, which has been used against both feline calicivirus (FCV) and murine norovirus (MNV). However, ethanol has limited efficacy against noroviruses [39], whereas bleach, although more effective at concentrations greater than 500 ppm [40], is limited to some surfaces, as it can cause corrosion of metals, craze plastics, and remove color from fabrics [41,42]. The CDC opinion on UV irradiation in environmental disinfection is that it remains an unresolved question [43].
There are also control programs meant to address food services [32,44] because they are such a frequent source of outbreaks. These programs focus on training managers and workers to identify warning signs, rigorously clean surfaces, wear gloves, and stay home when sick, all of which are useful protective practices [45]. Similar control programs already exist in some places for assisted living facilities and childcare facilities [45]. They generally involve very similar procedures—wipe down and clean surfaces, inform officials of any outbreaks, wash your hands, and wear gloves when cleaning vomit or feces.
The use of chemicals, such as bleach and ethanol, have limitations. For instance, occupational exposure to chemical disinfectants can cause lung damage [46]. Additionally, chemicals, such as hydrogen peroxide, peracetic acid, formaldehyde, sodium hypochlorite (household bleach), and beta-propiolactone, can be corrosive [47,48]. Further, observations have revealed that the disinfection performance of chemicals, such as chlorine and sodium hypochlorite, against norovirus surrogates is reduced in the presence of feces or other organic matter [49,50].
Minimal use of these chemicals, with the additional and safe use of UVC, will help curb HuNoVs. Still, for us to understand the disinfection efficacy of UVC, scientific evidence is needed. Unfortunately, at this time, model viral organisms (surrogates) are used to investigate disinfection efficacy, as HuNoVs, although cultivable [3], are challenging to use in this application (inactivation studies).

4. Surrogates: Considerations for Picking Norovirus Model Organisms for UVC Disinfection Studies

Previously, HuNoVs have been especially difficult to study because they could not be grown in tissue cultures [51]. Previous studies have involved acquiring samples from infected people, attempting to disinfect it with varying doses of disinfectants, and then intentionally infecting people through oral ingestion [52]. However, these studies are rare and cannot be used as the standard for measuring UV resistance or system design. Recently, developments on a tissue culture system for HuNoVs have been reported and used [53]. However, there are limitations to its use in inactivation studies, and the application is currently limited to human host-pathogen studies.
Thus, surrogates are almost always required for disinfection studies. Each has pros and cons, elaborated on in Table 1, which will be discussed further. Estimation of norovirus sensitivity to UVC radiation is from correlating UVC exposure’s impact on transcription using RT-qPCR or qPCR and cell cultures viability. RT-qPCR or qPCR results from surrogates’ studies, such as MNV, are then assumed to be similar in relationship to HuNoVs [12,54]. Given the circumstances, these are useful measurements. However, caution should be exercised during evaluation when using this approach, as RT-qPCR overestimates the number of infectious viral particles [55]. The viral reduction based on RT-qPCR will be lower due the overestimation of disinfected treatments.
It is also difficulty to account for differences between viruses or the impact of peak emission wavelengths of a UVC system.
Not all surrogates are equal. Thus, when picking the right surrogate for validation, environmental attributes, and genetic relatedness of surrogate to HuNoVs should not be the only attributes considered but other biological attributes as well [56,57]. For instance, HuNoVs can bind to histo-blood group antigens (HBGAs) in addition to infection and disease severity being associated with histo-blood group type [58,59]. Previous investigation has revealed that persons with blood group O phenotype are more likely to be infected with HuNoV, whereas those with B histo-blood group antigen have reduced risk of infection and disease symptom progression [58]. Surrogates, such as TV, bind to HBGAs [60]. Additionally, noroviruses bind to ligands beyond the histo-blood group antigens [61]. This includes receptors/co-factors (e.g., sialic acid), which can interact with the capsids of human norovirus [61,62]. Surrogates, such as FCV and MNV, bind to sialic acid on host cell surface [63,64]. A detailed review on of the two commonly used surrogates (FCV and MNV) from a food-safety perspective was published by Richards [65].
Although feline calicivirus (FCV) has been used as norovirus surrogate because of its cultivability, FCV is not an ideal candidate under some circumstances (Table 1). FCV is sensitive to low pH [72] and surface stress, including drying [85]. Therefore, if dried for UVC disinfection studies on dry surfaces, such as stainless steel, investigators need to consider the natural reduction due to the drying process. FCV also has different disinfection susceptibility under chlorine exposure [72,85] in addition to being more sensitive to UVC irradiation than HuNoVs [12].
On the other hand, murine norovirus (MNV) is an equally common surrogate for HuNoVs [69]. MNV is stable at a wider range of pH levels, is less sensitive to temperature, and shares genetic and molecular features with HuNoVs, such as size (diameter of 28–35 nm), icosahedral shape, and buoyant density (1.36 ± 0.04 g/cm3) [86,87,88]. However, MNV’s sensitivity to drying is like that of FCV, something that needs to be accounted for during validation. MNV is less sensitive to UVC than FCV and genetically closer to HuNoVs based on PCR studies [12,87].
Tulane virus (TV), the prototype recovirus strain, has been considered as a HuNoV surrogate [89]. Recovirus (ReCV) genus belongs to the family Caliciviridae and, just like HuNoV, is organized into three open reading frames (ORFs) [90,91]. TV recognizes the same ligand as HuNoV in oyster tissues [77,92]. The biological diversity and features of recovirus and clinical manifestations and disease progression in infected mammal organisms reflect HuNoVs properties more than with any prior surrogate [21]. Echovirus is like MNV in many ways and has been used as a surrogate [79]. MS2 has also been considered because it is a phage and easier to cultivate and test with. MS2 seems to be much more resistant than HuNoVs and so provides a large safety factor [12]. However, selecting a virus because of its high resilience may waste money and resources that could have been used protecting other pathways. Ultimately, when testing or designing new strategies for disinfection, one must understand and clearly justify the surrogate pick.

5. UVC Disinfection Studies That Utilized Norovirus Surrogates

Using deliberately contaminated stainless-steel surfaces, a previous study utilizing UVC at 260 nm to study the effects of 10–300 mWs/cm2 revealed that the murine norovirus-1 (MNV-1) titer was more sensitive than hepatitis A virus (HAV) [93]. The study also suggested that low doses of UVC can be used to decontaminated surfaces contaminated with HuNoV [93]. The effectiveness of UVC against MNV-1 has been associated with the disruption of the capsid protein and genomic RNA [75]. At 254 nm, with 25 mJ/cm2 UVC dose, a 3.6-log10 reduction was reported in a study carried out by Lee et al. [94]. This study also revealed higher MNV inactivation at high salt concentrations and temperatures (18 and 30 °C) compared to lower temperatures (−20 and 4 °C) [94].
Another study by Vimont et al. investigated the use of a pulsed-light device that emitted a broadband spectrum (200–1000 nm) and obtained a 3-log10 reduction using 3.45 J cm−2 in clear suspensions [95].

6. Considerations for Effective Use of UVC in Surface Disinfection

Per recent review by Raeiszadeh et al. [96], the COVID-19 pandemic has contributed to the increased consideration of UVC disinfection devices for disinfection. Proper use of UVC technology is required to guarantee disinfection when using devices such as Klaran WD array systems [97,98]. When disinfecting surfaces, considerations, such as type of surface (microstructural properties) being illuminated [99], intensity distribution projected onto target surface to be disinfected, and the distance between light source and target surfaces, should be factored into design and actual application. For instance, UVC disinfection may be more effective on plastic surfaces followed by stainless steel but lower on fabrics, such as poly-cotton [99].
One critical path for norovirus is through the food-service industry, where sick workers, contaminated water, or surface contact can contaminate food [25]. One strategy is to target all the pathways in the food-service industry. Since UV light can be used to disinfect surfaces and potentially even food surfaces, there is increasing interest for its use as a point-of-use disinfection method [32]. Examples of areas that could benefit from implementation of UVC technology include but are not limited to restrooms, kitchens, baggage claim areas, security checkpoints, and meeting rooms.
As discussed, surface transmission is one important pathway for norovirus outbreaks. However, before any research can be reasonably carried out, first, the methodology used during the study should be reviewed. The correct unit of light to be used to model UVC disinfection is fluence [100], or the amount of light through a sphere, divided by the cross section of said sphere. Studies that only measure exposure time and distance of UVC radiation from the surface being disinfected to determine disinfection efficacy of a system make universal application and replication hard and thus are insufficient. Although both time and distance are critical, they do not account for size, shape, reflection, temperature, or type of lamp, and therefore, results cannot be accurately transitioned into products/designs for real-world applications. Instead, fluence should be reported. For surfaces that absorb UV light, this simplifies from dose (mJ/cm2) to intensity (mW/cm2) multiplied by time (seconds) [101]. To ensure the correct measurement of the irradiance in experiments, it is best to use an optometer, such as the X1 MD-37-SC1–4, that is calibrated for the specific wavelength used in the experiment. Most optometers are designed for low-pressure mercury lamps, which radiate at 254 nm. Some of these, for example, will have a cut-off wavelength above 270 nm and are thus useless for measuring most LEDs or 222-nm filtered krypton lamps. Alternatives to optometers include potassium iodide acitometry [102,103], pre-existing disinfection systems with known irradiance at a well-defined point, and dosimeters selected for the correct wavelength [104].
In addition to the effect of the amount of light, the wavelength of light has a remarkable effect on disinfection rate. UVC LEDs have a peak wavelength between 215–280 nm, and that peak value can have a significant germicidal impact against many pathogens [105]. For example, with the same dose, 265–268 nm can increase disinfection of pathogens, such as SARS-CoV-2, by almost 1 log10 reduction value (1 LRV) compared to those with wavelengths >270 nm [106]. More studies are emphasizing that “not all wavelengths are created equal: [107,108]. Thus, measuring and specifying the wavelength and measurement tolerances used in a UVC system for disinfection is of critical importance for research, design, and implementation purposes. Spectrometers are available to perform such measurements, but spectrometers must be calibrated to ensure accurate intensities are reported.
The type of surface is also important during disinfection, as it has an impact on disinfection efficacy. The presence of small crevices can provide places for viruses to hide and avoid UVC exposure. On the other hand, reflecting surfaces can create numerous light passages, thus enhancing the disinfection efficiency [109]. For example, pathogens, including norovirus, on UVC-reflective materials, such as polished aluminum, may see 70% more light than measured with an optometer. That is because much of the light passes through the organism, but most will not be absorbed; it is then reflected through again. Since pathogens on porous absorbing materials may be shielded from most UVC light, lower inactivation efficacies are obtained. In surface disinfection, such reflection or coverage is accounted for simply by testing on different materials.
Physicochemical properties also impact UVC disinfection. Often, relative humidity is considered and reported only for studies involving aerosolized microorganisms. However, relative humidity effects the kill rate of viruses on surfaces and not just in air [110,111]. Temperature and humidity can affect survival of viruses [109].
Another limitation is around the way we consider populations. Often, we discuss log reduction values as simple additive reductions. This assumes that all viruses are the same and that if an exposure was able to kill, for instance, 90% in the first 10 s, then a 90% reduction within same time means identical results. This is erroneous because even if all the viruses were of the same exact genome, damage, if any, and micro-environment, which is far from certain, some viruses may be shaded, and others may interact with surfaces differently. For instance, 99.9% reduction within 10 s may be a reasonable approximation; it can be broken down at both low and high doses of any disinfectant, including UVC [112]. Therefore, for applications with either high, low, or a high dynamic range of dose, a log-normal distribution may be needed.
The ideal test of a norovirus surface disinfection system or study of sensitivity would cover a variety of relevant surface materials, with many different environmental conditions, with known, widely varied wavelength and fluence against the right surrogate. However, to the best of the authors’ knowledge, there is no such complete study for a norovirus because of the time and resources that are required to conduct such a study.
Autonomous navigation robots capable of recognizing surfaces with high probabilities of contamination are emerging [113]. It will be tremendous if such robots in future can detect the microstructural differences and adjust UVC dose accordingly. While these autonomous navigation robots are at work, it will be important that they have a feature to determine safe distance between them and nearest human beings and be able to warn them to be out of the way while disinfection is ongoing. They should be equipped with safety features, such as motion sensor, and be able to turn off UVC radiation when humans or animals approach [114] and wait for humans to move before proceeding with their disinfection work. Companies that make these products should ensure adequate safety features to protect humans against exposure to unsafe amount of UVC, as that could lead to advisories from guidance, compliance, and regulatory bodies in addition to other consequences [115,116].

7. Considerations for Conducting Water Disinfection Using UVC

Water disinfection has a great deal in common with surface disinfection. Fluence and wavelength are both still important, as are environmental factors. However, the number and types of environmental factors are different. Water disinfection reactors (flow-through systems with water exposed to UVC radiation) and water tanks do not always have reflective material and are almost always sealed. Water disinfection reactors mostly use reflective materials, such as polytetrafluoroethylene (PTFE), to enhance disinfection. During experiments, it is hard to measure dose (mJ/cm2) straightaway. To that end, inserting an optometer through a small hole or partially disassembling a system may be required. If so, then the hole should be as small as possible and correctly account for reflection multiply by 1 + R [117,118], with R being reflectivity of the inner reactor material. Another alternative is to use potassium iodide actinometry, but one must account for the UVC absorption [101].
Turbidity and absorption of fluid due to high concentration of Total Dissolved Solids (TDS), for instance, is one such different aspect that can impact inactivation efficacy [119]. While transmitting through air onto a surface, air is generally assumed to be 100% transparent, with low turbidity. None of the light passing through the air will be deflected away from the virus or be absorbed by gas. On the other hand, in liquid, it is possible to be turbid and absorbing to the extent of making a system completely ineffective, as has been demonstrated in aquacultures [120]. Hence, measurement of the UVC transmission and turbidity are needed. Noroviruses are also sensitive to pH [49,73]. Therefore, ethanol-containing acidic alcohol suspensions (e.g., 70% ethanol containing 1% citric acid) have more virucidal effect compared to 70% ethanol [121]. pH should always be reported as a factor during studies where liquids are involved. Just like on surfaces, norovirus deactivation rates also depend on temperature. It is vital to measure and control the temperature and pH of water during disinfection tests, as they directly influence the dynamics and distribution of other microbial assemblages [57,94,122].
Additionally, water supplies can have varying concentrations of chlorine or other disinfectant residuals. Some of these disinfectants are typically activated by UVC for various reasons but often through the formation of chlorine or oxygen radicals [123]. Therefore, it is critical to know the concentration of disinfectants in a test and recommended to design the study around them.
Furthermore, there is virus protection against UVC inactivation that could be expected when viral particles are in fecal matter or environment with organic matrix [124], which could lead to low viral inactivation efficacies by UVC. This has been observed when other agents are used in norovirus disinfection [125]. It is therefore important to consider properties of the materials to be disinfected. For the users to consider using UVC for norovirus infection control, they need to be guaranteed that the expected performances are obtained. Thus, this calls for a focus on the principles of disinfection and decontamination during UVC implementation toward norovirus infection control [35]. It is also important to consider if the type of water to be disinfected is static or flowing, as different types of water behave differently. All water is not equal; thus, the state (static or mobile) and physical as well as chemical composition of water will affect microbial stability and UVC dose requirements [126].

8. Radiation Safety Considerations

UVC light has safety concerns that prevent certain uses or require safety considerations during use [96]. Firstly, as a fact, UVC and even far UVC does not discriminate between pathogens and commensals. Because of that non-discriminatory nature and potential impact on the skin’s microbiome, any UV could induce human immune suppression [127]. It is important to know that commensals, especially those of the human skin surface, are crucial, as they induce protective responses that defend us against invasion and colonization by pathogens. The role of commensals (symbionts) in protective immunity has reviewed by Khan et al. [128], Li et al. [129], Byrd et al. [130], Grice and Segre [131], and Flowers and Segre [132].
The human skin microbiome has adapted to consume sparse nutrients available on our skin, in exchange for protecting us [130]. Although known to be stable regardless of perturbations, the kind of imbalance due to inactivation by UVC has not been studied. We predict that that due to dysbiosis (reduction of microbial diversity of beneficial bacteria due to indiscriminate inactivation), selection pressure, and enrichment of bacteria with high guanine–cytosine (%GC) composition bacteria on skin, we could potentially see an explosion of skin diseases and related conditions if exposure is for long period of time. Bacteria with high %GC, such as Actinobacteria, are more tolerant to UV [133]. If not safely implemented, UVC exposure at the airports when moving from gate A to Z or while waiting for hours to board the aircraft could enrich for high %GC content bacteria while inactivating beneficial ones with low %GC. Another example is in schools or hospitals, where there will be more exposure time. It will therefore be important that facility managers understand the spaces where the UVC can be safely and effectively implemented.
Since UVC is indiscriminate, it can damage all living cells it reaches. These cells are not restricted to mammalian cells but also bacteria and viruses for that matter. Although the good viruses that form part of the skin microbiome are poorly understood, they act as primary barrier to the external environment and help humans modulate cutaneous health [134]. We emphasize this because of the arguments that 222 nm is safe without regard for the critical role of the skin microbiome and potential for directed evolution of UVC resistant pathogens. Although erythema can be absent, irradiation at 500 mJ/cm2 using 222 nm UVC does decrease the number of bacteria while producing cyclobutene pyrimidine dimers (CPD) [135].
In fact, skin exposure can cause cancer with the right dose at almost all UVC wavelengths [136]. It can also cause retinal cancer and blindness [137]. It is reasonable that there is increasing interest in 222 nm, as it may not reach through the endoplasm of large cells and even less through dead skin cells or the lens of the eye, thus reducing the risk of cancer and blindness. As a result, 222-nm lamps are increasingly being used in open environments [43,138]. Although the promise of disinfecting an entire restaurant continuously to reduce norovirus spread sounds promising, several issues raised in this perspective should be considered during applications.
The other important concern is that although some studies show little to no corneal or skin damage at exposures of 100 s mJ/cm2 [138] from 222-nm light, they still show damage at doses of 1000 s mJ/cm2 [138]. Although there is hope that this effect is not cumulative, as epithelial shedding may provide added protection, this has not yet been tested, to the best of our knowledge. There has also been very little testing on humans—although one author exposed their eye briefly and informally and reported only mild irritation [139]. There has also been little consideration for variations like dry eyes, which may remove a critical protective barrier; cuts or abrasion of the skin, which may remove protective dead skin cells; or exposure to other sensitive areas. Thus, it is concerning to suggest that far UVC should be applied in airports, hospitals, schools, and homes with constant or long exposure time [43,138].
For emphasis, a dose of 100 mJ/cm2 at 222 nm reduces all pathogens by several orders of magnitude, hopefully without harming human cells [44]. However, just like with antibiotics, it should be noted from a skin microbiome perspective that the use of 222 nm or any far UVC on skin in general will not discriminate between pathogens and the “good” skin microbiome that is required for healthy skin. Skin microorganisms have important roles in the cutaneous immune system [130]. These “good” microbes also produce molecules that prevent skin colonization from other unwanted microorganisms or protect us by altering the behavior of the invaders, ensuring the protection and health of our biggest organ, the skin [130].
We therefore expect that indiscriminate frequent exposure of human skin to 222-nm light will likely inactivate symbionts and unbalance the taxonomic, phylogenetic, and functional potential of the microbiome, leading to a compromised cutaneous immune system, the consequence of which will be skin disorders, such as acne. The enrichment of UVC resistant is most likely to be for those skin microbes like Propionibacterium acnes, whose %GC content is high [45], and have less likelihood of forming enough dimers for inactivation. UVC application on skin will likely reduce microbial diversity due to inactivation of high AT commensals. A reduction of microbial diversity due to cutaneous microbial dysbiosis could lead to other conditions, such as psoriasis [140].
The demodex mites are part of normal skin flora and feed on microbes, such as P. acnes and sebum [131]. We speculate a taxonomic imbalance, which will in turn lead to functional imbalance, impacting immunity, and perhaps skin syndromes. Molecular, immunological metabolomic, and microbiological investigations are recommended in the future to unearth any potential functional dysregulation due to UVC usage on skin.
Regardless of the wavelength, the process for safe work with UVC light is similar. Wear long sleeves and pants that cover your whole body. Wear plastic or close-stitch gloves to absorb UVC light, which is also helpful in preventing smudges on your light source or reflectors. Wear plastic goggles to absorb UVC light. Most light sources will be sensitive to electro-static discharge (ESD), so consider wearing ESD shoes, bracelets, or boot covers. Some light sources require high voltages—such sources should not be used near flammables and should be isolated from users before powering on. Some light sources are made with glass and contain hazardous chemicals, so after use or breakage, follow the manufacturer’s disposal instructions.
The design and implementation of UVC disinfection reactors or sources should strive to prevent stray light from escaping. This can be done in water reactors by placing them ahead of a tubing of a material that will absorb UVC, such as most plastics and glasses. This forms a simple light baffle, which will absorb light but merely direct the water. A more complex tube shape, such as a u-bend or a mesh, can shorten the required distance. On surfaces, it is best if any design physically contacting the surface to be disinfected contains the light there.
The concerning potential disadvantage of the UVC technology involves potential dysregulation of both taxonomic, phylogenetic, and functional diversity of the skin microbiome. A survey on the composition, structure, and functional changes is thus recommended. For UVC to be effective, the target pathogens must be in direct contact with the UVC irradiation. Fortunately, UVC dosimeters, if correctly used, can be used for verification of UVC exposure [141]. Moreover, UVC can cause harmful effects on eyes and skin, and it is therefore not safe for use in disinfecting hands and skin [115,142].

9. The Promise of UVC for Norovirus

UVC disinfection of surfaces could have several critical norovirus-related applications. For example, washing fruit and vegetables may accidentally inoculate norovirus to surfaces. Additionally, chlorine is not allowed in many European countries and rarely desired anywhere because of its effect on the food and its residue both in the food and waste. However, recent studies have shown that food processing, which combines washing and application of UVC, can enable lighting all the relevant surfaces of various fresh fruits and vegetables [32,75,143,144,145,146]. UVC disinfection also promises an explosion hazard-free and chlorine-free way of disinfecting counter-tops, preparation areas, bathrooms, and any other high-touch surfaces repeatedly with little to no labor.
UVC could be and increasingly is used to disinfect wastewater to provide a low-impact way of protecting water estuaries and seafood [147,148,149]. Like with surface disinfection, there is significant interest in the synergy between TiO2 [147], H2O2, and Cl2 [150] with UVC to further improve disinfection performance. Such improvements may reduce the amount of time, power, and disinfectant required.
However, a thorough measurement of UVC disinfection efficiency of norovirus and its primary surrogate MNV in different environmental conditions would make design and implementation of UVC disinfection systems easier for water and surface disinfection. Exploring the factors of temperature, pH, humidity, wavelength, and surface type would allow designers to account for various situations in implementing their disinfection systems. Larger-scale adoption of UVC may still depend on both low barrier to entry and greater visibility of the benefits of disinfection.
UVC disinfection research, although eliminating some pathways, does not address many other problems. Many outbreaks stem from worker cleanliness and delayed detection. However, UVC could also play a role in tackling this difficult problem through timed auto-fluorescent measurement of pathogens [151,152,153]. Such systems might provide a method of scaling up point of outbreak monitoring by allowing, for example, restaurants, schools, and long-term care facilities to check for infection every shift. This could dramatically reduce the number of people exposed and the amount of exposure in an outbreak. However, such systems require significant further development—both in tools, such as high-sensitivity UVC detectors, high-speed switching UVC LEDs at multiple bands, analyzers, and databases, and more.
The 222 nm is not yet proven for long-term exposure in any surrogates and has not been tested in humans. However, such research, if proven safe, may provide a new route to continuous disinfection. Still, even if use of UVC does not prove safe in specific cases, it may still be useful in quickly dosing unoccupied public areas—especially in conjunction with other disinfectants, which may allow for more effective cleaning. Although traditional UVC sources, such as mercury lamps emitting UVC radiation at a peak wavelength at 254 nm, can be used, it is important to note that the overall log-inactivation efficacy at peak emission wavelength at 265 nm has been found to be high and most effective [154,155]. Furthermore, the use of low-pressure (LP) mercury lamps emitting radiation at 254 nm poses environmental concerns due to mercury content [156].

10. Conclusions

We have a long way to go in the fight against human norovirus. Perhaps the most important and exciting research direction is in developing methods for culture, growth, and measurement of HuNoVs because these developments underpin all others. However, the development of convenient detection may also reduce the outbreak time, while UVC disinfection of foods and services will help curb infectious pathways.
Until proven and the impact on the skin microbiome understood, shining UVC directly into occupied space should be avoided, as UVC does not have a mechanism to discriminate between pathogens and commensals, which are critical to our own health. Surveys utilizing shotgun metagenomics could help in evaluating the impact on commensals and associated changes in taxonomic and functional dynamics, including changes in secondary metabolites’ production.

Author Contributions

R.M.M. conceived the article. R.M.M. and J.H.D. designed the work, performed literature search, and contributed equally to the writing of the manuscript. R.V.R. revised the manuscript. All authors read, edited, and agreed to final manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This work received no specific grant from any funding agency.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data sharing not applicable. No new data were created or analyzed in this study.

Acknowledgments

Authors wish to thank Sébastien Blumenstein for proofreading and for invaluable feedback. Authors also thank Crystal IS for the support, especially Sanjay Kamtekar and Eoin Connolly.

Conflicts of Interest

R.M.M., J.H.D. and R.V.R. all receive salaries from Crystal IS, an Asahi Kasei company that manufactures UVC-LEDs.

References

  1. Green, K.Y.; Kaufman, S.S.; Nagata, B.M.; Chaimongkol, N.; Kim, D.Y.; Levenson, E.A.; Tin, C.M.; Yardley, A.B.; Johnson, J.A.; Barletta, A.B.F.; et al. Human norovirus targets enteroendocrine epithelial cells in the small intestine. Nat. Commun. 2020, 11, 2759. [Google Scholar] [CrossRef] [PubMed]
  2. Karst, S.M. Pathogenesis of Noroviruses, Emerging RNA Viruses. Viruses 2010, 2, 748–781. [Google Scholar] [CrossRef] [PubMed]
  3. Chhabra, P.; De Graaf, M.; Parra, G.I.; Chan, M.C.-W.; Green, K.; Martella, V.; Wang, Q.; White, P.A.; Katayama, K.; Vennema, H.; et al. Updated classification of norovirus genogroups and genotypes. J. Gen. Virol. 2019, 100, 1393–1406. [Google Scholar] [CrossRef] [PubMed]
  4. Bidalot, M.; Théry, L.; Kaplon, J.; De Rougemont, A.; Ambert-Balay, K. Emergence of new recombinant noroviruses GII.p16-GII.4 and GII.p16-GII.2, France, winter 2016 to 2017. Eurosurveillance 2017, 22, 1–5. [Google Scholar] [CrossRef] [Green Version]
  5. Li, X.; Liu, H.; Magalis, B.R.; Pond, S.L.K.; Volz, E.M. Molecular Evolution of Human Norovirus GII.2 Clusters. Front. Microbiol. 2021, 12, 655567. [Google Scholar] [CrossRef]
  6. Medici, M.C.; Tummolo, F.; Martella, V.; De Conto, F.; Arcangeletti, M.C.; Pinardi, F.; Ferraglia, F.; Chezzi, C.; Calderaro, A. Emergence of novel recombinant GII.P16_GII.2 and GII. P16_GII.4 Sydney 2012 norovirus strains in Italy, winter 2016/2017. New Microbiol. 2018, 41, 71–72. [Google Scholar]
  7. Tohma, K.; Lepore, C.J.; Siltz, L.; Parra, G.I. Phylogenetic Analyses Suggest that Factors Other Than the Capsid Protein Play a Role in the Epidemic Potential of GII.2 Norovirus. mSphere 2017, 2, e00187-17. [Google Scholar] [CrossRef] [Green Version]
  8. Niendorf, S.; Jacobsen, S.; Faber, M.; Eis-Hübinger, A.M.; Hofmann, J.; Zimmermann, O.; Höhne, M.; Bock, C.-T. Steep rise in norovirus cases and emergence of a new recombinant strain GII.P16-GII.2, Germany, winter 2016. Eurosurveillance 2017, 22, 30447. [Google Scholar] [CrossRef]
  9. Cheung, S.K.C.; Kwok, K.; Zhang, L.Y.; Mohammad, K.N.; Lui, G.C.Y.; Lee, N.; Nelson, E.A.S.; Lai, R.W.M.; Leung, T.K.; Chan, P.K.S.; et al. Higher Viral Load of Emerging Norovirus GII.P16-GII.2 than Pandemic GII.4 and Epidemic GII.17, Hong Kong, China. Emerg. Infect. Dis. 2019, 25, 119–122. [Google Scholar] [CrossRef] [Green Version]
  10. Bartsch, S.M.; Lopman, B.A.; Ozawa, S.; Hall, A.J.; Lee, B.Y. Global Economic Burden of Norovirus Gastroenteritis. PLoS ONE 2016, 11, e0151219. [Google Scholar] [CrossRef] [Green Version]
  11. Vinjé, J. Advances in Laboratory Methods for Detection and Typing of Norovirus. J. Clin. Microbiol. 2015, 53, 373–381. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Rockey, N.; Young, S.; Kohn, T.; Pecson, B.M.; Wobus, C.E.; Raskin, L.; Wigginton, K.R. UV Disinfection of Human Norovirus: Evaluating Infectivity Using a Genome-Wide PCR-Based Approach. Environ. Sci. Technol. 2020, 54, 2851–2858. [Google Scholar] [CrossRef] [PubMed]
  13. Green, K.Y. Norovirus infection in immunocompromised hosts. Clin. Microbiol. Infect. 2014, 20, 717–723. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Payne, D.C.; Vinje, J.; Szilagyi, P.G.; Edwards, K.M.; Staat, M.A.; Weinberg, G.; Hall, C.B.; Chappell, J.; Bernstein, D.I.; Curns, A.T.; et al. Norovirus and Medically Attended Gastroenteritis in U.S. Children. N. Engl. J. Med. 2013, 368, 1121–1130. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Harris, J.P.; Edmunds, W.J.; Pebody, R.; Brown, D.W.; Lopman, B.A. Deaths from Norovirus among the Elderly, England and Wales. Emerg. Infect. Dis. 2008, 14, 1546–1552. [Google Scholar] [CrossRef]
  16. Kobayashi, M.; Yoshizumi, S.; Kogawa, S.; Takahashi, T.; Ueki, Y.; Shinohara, M.; Mizukoshi, F.; Tsukagoshi, H.; Sasaki, Y.; Suzuki, R.; et al. Molecular Evolution of the Capsid Gene in Norovirus Genogroup I. Sci. Rep. 2015, 5, 13806. [Google Scholar] [CrossRef] [Green Version]
  17. Esposito, S.; Principi, N. Norovirus Vaccine: Priorities for Future Research and Development. Front. Immunol. 2020, 11, 1383. [Google Scholar] [CrossRef]
  18. Zhou, H.-L.; Chen, L.-N.; Wang, S.-M.; Tan, M.; Qiu, C.; Qiu, T.-Y.; Wang, X.-Y. Prevalence and Evolution of Noroviruses between 1966 and 2019, Implications for Vaccine Design. Pathogens 2021, 10, 1012. [Google Scholar] [CrossRef]
  19. Schneider, K.R.; Goodrich, R.M.; Mahovic, M.J.; Shukla, R. Preventing Foodborne Illness: Norovirus. EDIS 2019, 2005, 1–4. [Google Scholar] [CrossRef]
  20. Cannon, J.L.; Barclay, L.; Collins, N.R.; Wikswo, M.E.; Castro, C.J.; Magaña, L.C.; Gregoricus, N.; Marine, R.; Chhabra, P.; Vinjé, J. Genetic and Epidemiologic Trends of Norovirus Outbreaks in the United States from 2013 to 2016 Demonstrated Emergence of Novel GII.4 Recombinant Viruses. J. Clin. Microbiol. 2017, 55, 2208–2221. [Google Scholar] [CrossRef] [Green Version]
  21. Farkas, T. Rhesus enteric calicivirus surrogate model for human norovirus gastroenteritis. J. Gen. Virol. 2015, 96, 1504–1514. [Google Scholar] [CrossRef]
  22. Barker, J.; Vipond, I.B.; Bloomfield, S.F. Effects of cleaning and disinfection in reducing the spread of Norovirus contamination via environmental surfaces. J. Hosp. Infect. 2004, 58, 42–49. [Google Scholar] [CrossRef] [PubMed]
  23. Canales, R.A.; Reynolds, K.A.; Wilson, A.M.; Fankem, S.L.; Weir, M.H.; Rose, J.B.; Abd-Elmaksoud, S.; Gerba, C.P. Modeling the role of fomites in a norovirus outbreak. J. Occup. Environ. Hyg. 2019, 16, 16–26. [Google Scholar] [CrossRef] [PubMed]
  24. Boxman, I.; Dijkman, R.; Verhoef, L.; Maat, A.; Van Dijk, G.; Vennema, H.; Koopmans, M. Norovirus on Swabs Taken from Hands Illustrate Route of Transmission: A Case Study. J. Food Prot. 2009, 72, 1753–1755. [Google Scholar] [CrossRef] [PubMed]
  25. Kwan, H.S.; Chan, P.K.S.; Chan, M.C.W. Chapter 2—Overview of Norovirus as a Foodborne Pathogen. In The Norovirus; Chan, P.K.S., Ed.; Academic Press: Cambridge, MA, USA, 2017; pp. 21–30. ISBN 978-0-12-804177-2. [Google Scholar]
  26. Maunula, L.; Miettinen, I.T.; Von Bonsdorff, C.-H. Norovirus Outbreaks from Drinking Water. Emerg. Infect. Dis. 2005, 11, 1716–1721. [Google Scholar] [CrossRef]
  27. Robilotti, E.; Deresinski, S.; Pinsky, B.A. Norovirus. Clin. Microbiol. Rev. 2015, 28, 134–164. [Google Scholar] [CrossRef] [Green Version]
  28. ECDC Facts about Norovirus. Available online: https://www.ecdc.europa.eu/en/norovirus-infection/facts (accessed on 1 December 2021).
  29. Cromeans, T.L.; Kahler, A.M.; Hill, V.R. Inactivation of Adenoviruses, Enteroviruses, and Murine Norovirus in Water by Free Chlorine and Monochloramine. Appl. Environ. Microbiol. 2010, 76, 1028–1033. [Google Scholar] [CrossRef] [Green Version]
  30. Cleveland Clinic Norovirus: Symptoms, Causes, Treatments. Available online: https://my.clevelandclinic.org/health/diseases/17703-norovirus (accessed on 1 December 2021).
  31. Brunette, G.W. CDC Yellow Book 2018: Health Information for International Travel; Oxford University Press: Oxford, UK, 2017; Volume 66, pp. 1157–1158. ISBN 9780190628611. [Google Scholar]
  32. Koutchma, T.; Popović, V. Chapter 5—UV Light-Emitting Diodes (LEDs) and Food Safety. In Ultraviolet LED Technology for Food Applications; Koutchma, T., Ed.; Academic Press: Cambridge, MA, USA, 2019; pp. 91–117. ISBN 978-0-12-817794-5. [Google Scholar]
  33. Koutchma, T. UV Light for Processing Foods. Ozone Sci. Eng. 2008, 30, 93–98. [Google Scholar] [CrossRef]
  34. MacCannell, T.; Umscheid, C.A.; Agarwal, R.K.; Lee, I.; Kuntz, G.; Stevenson, K.B. Guideline for the Prevention and Control of Norovirus Gastroenteritis Outbreaks in Healthcare Settings. Infect. Control Hosp. Epidemiol. 2011, 32, 939–969. [Google Scholar] [CrossRef] [Green Version]
  35. Barclay, L.; Park, G.; Vega, E.; Hall, A.; Parashar, U.; Vinje, J.; Lopman, B. Infection control for norovirus. Clin. Microbiol. Infect. 2014, 20, 731–740. [Google Scholar] [CrossRef] [Green Version]
  36. Vinnard, C.; Lee, I.; Linkin, D.R. Successful control of a norovirus outbreak among attendees of a hospital teaching conference. Am. J. Infect. Control 2012, 40, 73–74. [Google Scholar] [CrossRef] [PubMed]
  37. Xu, Q. Epidemic and control strategy on nosocomial outbreak of norovirus gastroenteritis. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2008, 30, 614–617. [Google Scholar] [PubMed]
  38. Georgiadou, S.P.; Loukeris, D.; Smilakou, S.; Daikos, G.L.; Sipsas, N.V. Effective control of an acute gastroenteritis outbreak due to norovirus infection in a hospital ward in Athens, Greece, April 2011. Eurosurveillance 2011, 16, 19915. [Google Scholar] [CrossRef] [PubMed]
  39. Escudero-Abarca, B.I.; Goulter, R.; Arbogast, J.W.; Leslie, R.A.; Green, K.; Jaykus, L. Efficacy of alcohol-based hand sanitizers against human norovirus using RNase-RT-qPCR with validation by human intestinal enteroid replication. Lett. Appl. Microbiol. 2020, 71, 605–610. [Google Scholar] [CrossRef] [PubMed]
  40. Sato, J.; Miki, M.; Hitomi, J.; Tokuda, H.; Katayama, K.; Kubota, H.; Todaka-Takai, R. Effects of disinfectants against norovirus virus-like particles predict norovirus inactivation. Microbiol. Immunol. 2016, 60, 609–616. [Google Scholar] [CrossRef]
  41. Crawford, M. How Clean Is Clean? Chemistry Can Damage Medical Equipment In the Quest to Meet Stringent Guidelines. Biomed. Instrum. Technol. 2014, 48, 260–263. [Google Scholar] [CrossRef]
  42. Tyan, K.; Jin, K.; Kang, J. Novel colour additive for bleach disinfectant wipes reduces corrosive damage on stainless steel. J. Hosp. Infect. 2019, 103, 227–230. [Google Scholar] [CrossRef]
  43. Buonanno, M.; Welch, D.; Shuryak, I.; Brenner, D.J. Far-UVC light (222 nm) efficiently and safely inactivates airborne human coronaviruses. Sci. Rep. 2020, 10, 10285. [Google Scholar] [CrossRef]
  44. Hessling, M.; Haag, R.; Sieber, N.; Vatter, P. The Impact of Far-UVC Radiation (200-230 Nm) on Pathogens, Cells, Skin, and Eyes—A Collection and Analysis of a Hundred Years of Data. GMS Hyg. Infect. Control 2021, 16, 1–17. [Google Scholar] [CrossRef]
  45. Minegishi, K.; Aikawa, C.; Furukawa, A.; Watanabe, T.; Nakano, T.; Ogura, Y.; Ohtsubo, Y.; Kurokawa, K.; Hayashi, T.; Maruyama, F.; et al. Complete Genome Sequence of a Propionibacterium acnes Isolate from a Sarcoidosis Patient. Genome Announc. 2013, 1, e00016-12. [Google Scholar] [CrossRef] [Green Version]
  46. Dumas, O.; Varraso, R.; Boggs, K.M.; Quinot, C.; Zock, J.-P.; Henneberger, P.K.; Speizer, F.E.; Le Moual, N.; Camargo, C.A., Jr. Association of Occupational Exposure to Disinfectants with Incidence of Chronic Obstructive Pulmonary Disease Among US Female Nurses. JAMA Netw. Open 2019, 2, e1913563. [Google Scholar] [CrossRef] [PubMed]
  47. Nicklas, W.; Böhm, K.H.; Richter, B. [Studies on the corrosive action of some disinfectants suitable for aerosol-disinfection (author’s transl)]. Zentralbl. Bakteriol. Mikrobiol. Hyg. B 1981, 173, 374–381. [Google Scholar] [PubMed]
  48. Cao, C. Chemical Disinfectants for Inactivation of Human Norovirus Surrogates. Master’s Thesis, University of Tennessee, Knoxville, TN, USA, 2013. [Google Scholar]
  49. Poschetto, L.F.; Ike, A.; Papp, T.; Mohn, U.; Böhm, R.; Marschang, R.E. Comparison of the Sensitivities of Noroviruses and Feline Calicivirus to Chemical Disinfection under Field-Like Conditions. Appl. Environ. Microbiol. 2007, 73, 5494–5500. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. Baert, L.; Vandekinderen, I.; Devlieghere, F.; Van Coillie, E.; Debevere, J.; Uyttendaele, M. Efficacy of Sodium Hypochlorite and Peroxyacetic Acid to Reduce Murine Norovirus 1, B40-8, Listeria monocytogenes, and Escherichia coli O157:H7 on Shredded Iceberg Lettuce and in Residual Wash Water. J. Food Prot. 2009, 72, 1047–1054. [Google Scholar] [CrossRef] [PubMed]
  51. Oka, T.; Stoltzfus, G.T.; Zhu, C.; Jung, K.; Wang, Q.; Saif, L.J. Attempts to grow human noroviruses, a sapovirus, and a bovine norovirus in vitro. PLoS ONE 2018, 13, e0178157. [Google Scholar] [CrossRef]
  52. Keswick, B.H.; Satterwhite, T.K.; Johnson, P.C.; DuPont, H.L.; Secor, S.L.; Bitsura, J.A.; Gary, G.W.; Hoff, J.C. Inactivation of Norwalk virus in drinking water by chlorine. Appl. Environ. Microbiol. 1985, 50, 261–264. [Google Scholar] [CrossRef] [Green Version]
  53. Ettayebi, K.; Crawford, S.E.; Murakami, K.; Broughman, J.R.; Karandikar, U.; Tenge, V.; Neill, F.H.; Blutt, S.E.; Zeng, X.-L.; Qu, L.; et al. Replication of human noroviruses in stem cell-derived human enteroids. Science 2016, 353, 1387–1393. [Google Scholar] [CrossRef]
  54. Rönnqvist, M.; Mikkelä, A.; Tuominen, P.; Salo, S.; Maunula, L. Ultraviolet Light Inactivation of Murine Norovirus and Human Norovirus GII: PCR May Overestimate the Persistence of Noroviruses Even When Combined with Pre-PCR Treatments. Food Environ. Virol. 2013, 6, 48–57. [Google Scholar] [CrossRef]
  55. Manuel, C.S.; Moore, M.D.; Jaykus, L.-A. Predicting human norovirus infectivity—Recent advances and continued challenges. Food Microbiol. 2018, 76, 337–345. [Google Scholar] [CrossRef]
  56. Sinclair, R.G.; Rose, J.B.; Hashsham, S.A.; Gerba, C.P.; Haas, C. Criteria for Selection of Surrogates Used to Study the Fate and Control of Pathogens in the Environment. Appl. Environ. Microbiol. 2012, 78, 1969–1977. [Google Scholar] [CrossRef] [Green Version]
  57. Hirneisen, K.A.; Kniel, K.E. Comparing Human Norovirus Surrogates: Murine Norovirus and Tulane Virus. J. Food Prot. 2013, 76, 139–143. [Google Scholar] [CrossRef] [PubMed]
  58. Hutson, A.M.; Atmar, R.L.; Graham, D.Y.; Estes, M.K. Norwalk Virus Infection and Disease Is Associated with ABO Histo–Blood Group Type. J. Infect. Dis. 2002, 185, 1335–1337. [Google Scholar] [CrossRef] [PubMed]
  59. Tan, M.; Jiang, X. Norovirus Gastroenteritis, Carbohydrate Receptors, and Animal Models. PLoS Pathog. 2010, 6, e1000983. [Google Scholar] [CrossRef] [PubMed]
  60. Farkas, T.; Cross, R.W.; Hargitt, E., 3rd; Lerche, N.W.; Morrow, A.L.; Sestak, K. Genetic Diversity and Histo-Blood Group Antigen Interactions of Rhesus Enteric Caliciviruses. J. Virol. 2010, 84, 8617–8625. [Google Scholar] [CrossRef] [Green Version]
  61. Almand, E.A.; Moore, M.D.; Jaykus, L.-A. Norovirus Binding to Ligands Beyond Histo-Blood Group Antigens. Front. Microbiol. 2017, 8, 2549. [Google Scholar] [CrossRef] [Green Version]
  62. Varki, A. Multiple Changes in Sialic Acid Biology During Human Evolution. Glycoconj J. 2009, 26, 231–245. [Google Scholar] [CrossRef]
  63. Stuart, A.D.; Brown, T.D.K. α2,6-Linked sialic acid acts as a receptor for Feline calicivirus. J. Gen. Virol. 2007, 88, 177–186. [Google Scholar] [CrossRef]
  64. Taube, S.; Perry, J.W.; Yetming, K.; Patel, S.P.; Auble, H.; Shu, L.; Nawar, H.F.; Lee, C.H.; Connell, T.D.; Shayman, J.A.; et al. Ganglioside-Linked Terminal Sialic Acid Moieties on Murine Macrophages Function as Attachment Receptors for Murine Noroviruses. J. Virol. 2009, 83, 4092–4101. [Google Scholar] [CrossRef] [Green Version]
  65. Richards, G.P. Critical Review of Norovirus Surrogates in Food Safety Research: Rationale for Considering Volunteer Studies. Food Environ. Virol. 2012, 4, 6–13. [Google Scholar] [CrossRef] [Green Version]
  66. Park, G.W.; Sobsey, M.D. Simultaneous Comparison of Murine Norovirus, Feline Calicivirus, Coliphage MS2, and GII.4 Norovirus to Evaluate the Efficacy of Sodium Hypochlorite Against Human Norovirus on a Fecally Soiled Stainless Steel Surface. Foodborne Pathog. Dis. 2011, 8, 1005–1010. [Google Scholar] [CrossRef]
  67. Nims, R.; Plavsic, M. Inactivation of Caliciviruses. Pharmaceuticals 2013, 6, 358–392. [Google Scholar] [CrossRef] [PubMed]
  68. Bae, J.; Schwab, K.J. Evaluation of Murine Norovirus, Feline Calicivirus, Poliovirus, and MS2 as Surrogates for Human Norovirus in a Model of Viral Persistence in Surface Water and Groundwater. Appl. Environ. Microbiol. 2008, 74, 477–484. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  69. Tian, P.; Yang, D.; Quigley, C.; Chou, M.; Jiang, X. Inactivation of the Tulane Virus, a Novel Surrogate for the Human Norovirus. J. Food Prot. 2013, 76, 712–718. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  70. Mormann, S.; Heißenberg, C.; Pfannebecker, J.; Becker, B. Tenacity of Human Norovirus and the Surrogates Feline Calicivirus and Murine Norovirus during Long-Term Storage on Common Nonporous Food Contact Surfaces. J. Food Prot. 2015, 78, 224–229. [Google Scholar] [CrossRef]
  71. Oguma, K.; Rattanakul, S. UV Inactivation of Viruses in Water: Its Potential to Mitigate Current and Future Threats of Viral Infectious Diseases. Jpn. J. Appl. Phys. 2021, 60, 110502. [Google Scholar] [CrossRef]
  72. Ohmine, T.; Narai, S.; Matsubara, T.; Nomura, T.; Oda, K.; Fukushi, M.; Irie, T.; Komatsu, T.; Tohya, Y.; Sakaguchi, T. Eligibility of Feline Calicivirus for a Surrogate of Human Norovirus in Comparison with Murine Norovirus, Poliovirus and Coxsackievirus. Biocontrol Sci. 2018, 23, 145–149. [Google Scholar] [CrossRef] [Green Version]
  73. Park, G.W.; Barclay, L.; Macinga, D.; Charbonneau, D.; Pettigrew, C.A.; Vinje, J. Comparative Efficacy of Seven Hand Sanitizers against Murine Norovirus, Feline Calicivirus, and GII.4 Norovirus. J. Food Prot. 2010, 73, 2232–2238. [Google Scholar] [CrossRef]
  74. Radford, A.D.; Coyne, K.P.; Dawson, S.; Porter, C.J.; Gaskell, R.M. Feline calicivirus. Vet. Res. 2007, 38, 319–335. [Google Scholar] [CrossRef] [Green Version]
  75. Park, D.; Shahbaz, H.; Kim, S.-H.; Lee, M.; Lee, W.; Oh, J.-W.; Lee, D.-U.; Park, J. Inactivation efficiency and mechanism of UV-TiO2 photocatalysis against murine norovirus using a solidified agar matrix. Int. J. Food Microbiol. 2016, 238, 256–264. [Google Scholar] [CrossRef]
  76. Hewitt, J.; Rivera-Aban, M.; Greening, G. Evaluation of murine norovirus as a surrogate for human norovirus and hepatitis A virus in heat inactivation studies. J. Appl. Microbiol. 2009, 107, 65–71. [Google Scholar] [CrossRef]
  77. Polo, D.; Schaeffer, J.; Teunis, P.; Buchet, V.; Le Guyader, F.S. Infectivity and RNA Persistence of a Norovirus Surrogate, the Tulane Virus, in Oysters. Front. Microbiol. 2018, 9, 716. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  78. Cromeans, T.; Park, G.W.; Costantini, V.; Lee, D.; Wang, Q.; Farkas, T.; Lee, A.; Vinjé, J. Comprehensive Comparison of Cultivable Norovirus Surrogates in Response to Different Inactivation and Disinfection Treatments. Appl. Environ. Microbiol. 2014, 80, 5743–5751. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  79. Park, G.; Linden, K.G.; Sobsey, M. Inactivation of murine norovirus, feline calicivirus and echovirus 12 as surrogates for human norovirus (NoV) and coliphage (F+) MS2 by ultraviolet light (254 nm) and the effect of cell association on UV inactivation. Lett. Appl. Microbiol. 2011, 52, 162–167. [Google Scholar] [CrossRef] [PubMed]
  80. Huber, M.; Watson, K.A.; Selinka, H.-C.; Carthy, C.M.; Klingel, K.; McManus, B.M.; Kandolf, R. Cleavage of RasGAP and Phosphorylation of Mitogen-Activated Protein Kinase in the Course of Coxsackievirus B3 Replication. J. Virol. 1999, 73, 3587–3594. [Google Scholar] [CrossRef] [Green Version]
  81. Hammon, W.M.; Ludwig, E.H.; Pavia, R.A.; McCloskey, L.W.; Sather, G.E. Problems Raised by Certain ECHO Viruses in the Attempted Laboratory Detection of Poliomyelitis Virus Infection. Ann. N. Y. Acad. Sci. 1957, 67, 304–310. [Google Scholar] [CrossRef]
  82. Dawson, D.; Paish, A.; Staffell, L.; Seymour, I.; Appleton, H. Survival of viruses on fresh produce, using MS2 as a surrogate for norovirus. J. Appl. Microbiol. 2005, 98, 203–209. [Google Scholar] [CrossRef]
  83. Tung-Thompson, G.; Libera, D.A.; Koch, K.L.; de los Reyes, F.L., III; Jaykus, L.-A. Aerosolization of a Human Norovirus Surrogate, Bacteriophage MS2, during Simulated Vomiting. PLoS ONE 2015, 10, e0134277. [Google Scholar] [CrossRef]
  84. Seo, K.; Lee, J.E.; Lim, M.Y.; Ko, G. Effect of Temperature, pH, and NaCl on the Inactivation Kinetics of Murine Norovirus. J. Food Prot. 2012, 75, 533–540. [Google Scholar] [CrossRef]
  85. Doultree, J.; Druce, J.; Birch, C.; Bowden, D.; Marshall, J. Inactivation of feline calicivirus, a Norwalk virus surrogate. J. Hosp. Infect. 1999, 41, 51–57. [Google Scholar] [CrossRef]
  86. Green, K. Human Caliciviruses. Fields Virol. 2001, 1, 841–874. [Google Scholar]
  87. Karst, S.M.; Wobus, C.E.; Lay, M.; Davidson, J.; Virgin, H.W. STAT1-Dependent Innate Immunity to a Norwalk-Like Virus. Science 2003, 299, 1575–1578. [Google Scholar] [CrossRef] [PubMed]
  88. Cannon, J.L.; Papafragkou, E.; Park, G.W.; Osborne, J.; Jaykus, L.-A.; Vinjé, J. Surrogates for the Study of Norovirus Stability and Inactivation in the Environment: A Comparison of Murine Norovirus and Feline Calicivirus. J. Food Prot. 2006, 69, 2761–2765. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  89. Drouaz, N.; Schaeffer, J.; Farkas, T.; Le Pendu, J.; Le Guyader, F.S. Tulane Virus as a Potential Surrogate to Mimic Norovirus Behavior in Oysters. Appl. Environ. Microbiol. 2015, 81, 5249–5256. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  90. Farkas, T.; Sestak, K.; Wei, C.; Jiang, X. Characterization of a Rhesus Monkey Calicivirus Representing a New Genus of Caliciviridae. J. Virol. 2008, 82, 5408–5416. [Google Scholar] [CrossRef] [Green Version]
  91. Park, B.-J.; Ahn, H.-S.; Han, S.-H.; Go, H.-J.; Lyoo, E.-L.; Choi, C.; Myoung, J.; Lee, J.-B.; Park, S.-Y.; Song, C.-S.; et al. Coding-Complete Genome Sequence of a Recombinant Human Norovirus Strain Identified as Subtype GII.p12_GII.3. Microbiol. Resour. Announc. 2020, 9. [Google Scholar] [CrossRef] [Green Version]
  92. Le Guyader, F.S.; Maalouf, H.; Le Pendu, J. Oysters and norovirus: Something special? Virologie 2013, 17, 253–263. [Google Scholar] [CrossRef]
  93. Park, S.Y.; Kim, A.-N.; Lee, K.-H.; Ha, S.-D. Ultraviolet-C efficacy against a norovirus surrogate and hepatitis A virus on a stainless steel surface. Int. J. Food Microbiol. 2015, 211, 73–78. [Google Scholar] [CrossRef]
  94. Lee, J.; Zoh, K.; Ko, G. Inactivation and UV Disinfection of Murine Norovirus with TiO2 under Various Environmental Conditions. Appl. Environ. Microbiol. 2008, 74, 2111–2117. [Google Scholar] [CrossRef] [Green Version]
  95. Vimont, A.; Fliss, I.; Jean, J.; Deng, Y.; Liu, X.; Wu, J.; Lee, J.; Chen, S.; Cheng, Y.; Zhang, C.; et al. Efficacy and Mechanisms of Murine Norovirus Inhibition by Pulsed-Light Technology. Appl. Environ. Microbiol. 2015, 81, 2950–2957. [Google Scholar] [CrossRef] [Green Version]
  96. Raeiszadeh, M.; Adeli, B. A Critical Review on Ultraviolet Disinfection Systems against COVID-19 Outbreak: Applicability, Validation, and Safety Considerations. ACS Photon. 2020, 7, 2941–2951. [Google Scholar] [CrossRef]
  97. Mariita, R.M.; Miller, A.C.W.; Randive, R.V. Evaluation of the virucidal efficacy of Klaran UVC LEDs against surface-dried norovirus. Access Microbiol. 2021, 4, 000323. [Google Scholar] [CrossRef]
  98. Mariita, R.M.; Randive, R.V. Disinfection of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium and Acinetobacter baumannii using Klaran WD array system. Access Microbiol. 2021, 3, 000194. [Google Scholar] [CrossRef] [PubMed]
  99. Mariita, R.M.; Davis, J.H.; Lottridge, M.M.; Randive, R.V. Shining light on multi-drug resistant Candida auris: Ultraviolet-C disinfection, wavelength sensitivity, and prevention of biofilm formation of an emerging yeast pathogen. MicrobiologyOpen 2022, 11, e1261. [Google Scholar] [CrossRef]
  100. Bolton, J.R.; Cotton, C.A. The Ultraviolet Disinfection Handbook; American Water Works Association: Denver, CO, USA, 2011; ISBN 1-61300-077-4. [Google Scholar]
  101. Jacques, S. On Optical Irradiance versus Fluence Rate. Available online: https://omlc.org/news/sep05/irradiancemovie.html (accessed on 25 October 2021).
  102. Rahn, R.O. Potassium Iodide as a Chemical Actinometer for 254 nm Radiation: Use of lodate as an Electron Scavenger. Photochem. Photobiol. 1997, 66, 450–455. [Google Scholar] [CrossRef]
  103. Rahn, R.O.; Bolton, J.; Stefan, M.I. The Iodide/Iodate Actinometer in UV Disinfection: Determination of the Fluence Rate Distribution in UV Reactors. Photochem. Photobiol. 2006, 82, 611–615. [Google Scholar] [CrossRef]
  104. UVC Dosimeter Verifies UVC Exposure. Available online: https://www.americanultraviolet.com/germicidal-healthcare-solutions/uvc-dosimeter.html (accessed on 22 November 2021).
  105. Bondokov, R.T.; Branagan, S.P.; Ishigami, N.; Grandusky, J.; Nagatomi, T.; Tatsuta, K.; Miebach, T.; Chen, J. Two-Inch Aluminum Nitride (AIN) Single Crystal Growth for Commercial Applications. ECS Trans. 2021, 104, 37–48. [Google Scholar] [CrossRef]
  106. Mariita, R.M.; Wilson Miller, A.C.; Randive, R.V.; McKay, L.G.A.; Storm, N.; Griffiths, A. Disinfection of SARS-CoV-2 Using UVC Reveals Wavelength Sensitivity Contributes towards Rapid Virucidal Activity. medRxiv 2021, 1–13. Available online: https://www.medrxiv.org/content/10.1101/2021.06.30.21259769v2 (accessed on 29 November 2021).
  107. Mariita, R.M.; Peterson, J.W. Not All Wavelengths Are Created Equal: Disinfection of SARS-CoV-2 Using UVC Radiation Is Wavelength-Dependent. Access Microbiol. 2021, 3, 276. [Google Scholar] [CrossRef]
  108. Minamikawa, T.; Koma, T.; Suzuki, A.; Mizuno, T.; Nagamatsu, K.; Arimochi, H.; Tsuchiya, K.; Matsuoka, K.; Yasui, T.; Yasutomo, K.; et al. Quantitative evaluation of SARS-CoV-2 inactivation using a deep ultraviolet light-emitting diode. Sci. Rep. 2021, 11, 1–9. [Google Scholar] [CrossRef]
  109. De Abajo, F.J.G.; Hernández, R.J.; Kaminer, I.; Meyerhans, A.; Rosell-Llompart, J.; Sanchez-Elsner, T. Back to Normal: An Old Physics Route to Reduce SARS-CoV-2 Transmission in Indoor Spaces. ACS Nano 2020, 14, 7704–7713. [Google Scholar] [CrossRef]
  110. Tseng, C.-C.; Li, C.-S. Inactivation of Viruses on Surfaces by Ultraviolet Germicidal Irradiation. J. Occup. Environ. Hyg. 2007, 4, 400–405. [Google Scholar] [CrossRef]
  111. Gallardo-Flores, C.; Colpitts, C. Cyclophilins and Their Roles in Hepatitis C Virus and Flavivirus Infections: Perspectives for Novel Antiviral Approaches. Pathogens 2021, 10, 902. [Google Scholar] [CrossRef] [PubMed]
  112. Najm, I. An alternative interpretation of disinfection kinetics. J. Am. Water Work. Assoc. 2006, 98, 93–101. [Google Scholar] [CrossRef]
  113. Hong, H.; Shin, W.; Oh, J.; Lee, S.; Kim, T.; Lee, W.; Choi, J.; Suh, S.; Kim, K. Standard for the Quantification of a Sterilization Effect Using an Artificial Intelligence Disinfection Robot. Sensors 2021, 21, 7776. [Google Scholar] [CrossRef] [PubMed]
  114. NEA Advises the Public Against Purchasing Unsafe Ultraviolet-C Sterilisers for Home Use. Available online: https://www.nea.gov.sg/media/news/advisories/index/nea-advises-the-public-against-purchasing-unsafe-ultraviolet-c-sterilisers-for-home-use (accessed on 29 November 2021).
  115. Risk of Exposure to Unsafe Levels of Radiation with Safe-T-Lite UV WAND: FDA Safety Communication. Available online: https://www.nea.gov.sg/media/news/advisories/index/nea-advises-the-public-against-purchasing-unsafe-ultraviolet-c-sterilisers-for-home-use (accessed on 29 November 2021).
  116. Consumer Council. Consumers Reminded of Broad Limitations on Portable UV Disinfection Devices Do Not Expose Skin and Eyes to UVC to Avoid Injuries. Available online: https://www.consumer.org.hk/en/press-release/532-portable-uv-disinfection-devices (accessed on 29 November 2021).
  117. Kheyrandish, A.; Mohseni, M.; Taghipour, F. Protocol to Determine Radiant Power Output and Fluence in UV LED Systems. 2019. Available online: https://uvsolutionsmag.com/articles/2019/protocol-to-determine-radiant-power-output-and-fluence-in-uv-led-systems/ (accessed on 29 November 2021).
  118. Bolton, J.R.; Mayor-Smith, I.; Linden, K.G. Rethinking the Concepts of Fluence (UV Dose) and Fluence Rate: The Importance of Photon-based Units—A Systemic Review. Photochem. Photobiol. 2015, 91, 1252–1262. [Google Scholar] [CrossRef] [PubMed]
  119. Nguyen, T.M.H.; Suwan, P.; Koottatep, T.; Beck, S.E. Application of a novel, continuous-feeding ultraviolet light emitting diode (UV-LED) system to disinfect domestic wastewater for discharge or agricultural reuse. Water Res. 2019, 153, 53–62. [Google Scholar] [CrossRef]
  120. Gullian, M.; Espinosa-Faller, F.J.; Núñez, A.; López-Barahona, N. Effect of turbidity on the ultraviolet disinfection performance in recirculating aquaculture systems with low water exchange. Aquac. Res. 2011, 43, 595–606. [Google Scholar] [CrossRef]
  121. Sato, S.; Matsumoto, N.; Hisaie, K.; Uematsu, S. Alcohol abrogates human norovirus infectivity in a pH-dependent manner. Sci. Rep. 2020, 10, 15878. [Google Scholar] [CrossRef]
  122. Casas-Monroy, O.; Linley, R.D.; Chan, P.-S.; Kydd, J.; Byllaardt, J.V.; Bailey, S. Evaluating efficacy of filtration + UV-C radiation for ballast water treatment at different temperatures. J. Sea Res. 2018, 133, 20–28. [Google Scholar] [CrossRef]
  123. Cheng, Z.; Ling, L.; Shang, C. Near-Ultraviolet Light-Driven Photocatalytic Chlorine Activation Process with Novel Chlorine Activation Mechanisms. ACS EST Water 2021, 1, 2067–2075. [Google Scholar] [CrossRef]
  124. Lin, Q.; Lim, J.Y.C.; Xue, K.; Yew, P.Y.M.; Owh, C.; Chee, P.L.; Loh, X.J. Sanitizing agents for virus inactivation and disinfection. VIEW 2020, 1, e16. [Google Scholar] [CrossRef]
  125. Jubinville, E.; Girard, M.; Trudel-Ferland, M.; Fliss, I.; Jean, J. Inactivation of Murine Norovirus Suspended in Organic Matter Simulating Actual Conditions of Viral Contamination. Food Environ. Virol. 2021, 13, 544–552. [Google Scholar] [CrossRef] [PubMed]
  126. Verhoeven, S.; Sealey, L.; Patterson, J.; Odegaard, C. Not All Water Is Created Equal: The Effects of Water Characteristics on MS2 Stability and Dose Response. Available online: https://www.iuva.org/resources/2018_IUVA_Americas_Conference/Technical-Proceedings/Validation%20and%20Lab%20Approaches/Verhoeven_Shawn-Not-All-Water-Is-Created-Equal.pdf (accessed on 22 November 2021).
  127. Patra, V.; Byrne, S.N.; Wolf, P. The Skin Microbiome: Is It Affected by UV-induced Immune Suppression? Front. Microbiol. 2016, 7, 1235. [Google Scholar] [CrossRef] [Green Version]
  128. Khan, R.; Petersen, F.C.; Shekhar, S. Commensal bacteria: An emerging player in defense against respiratory pathogens. Front. Immunol. 2019, 10, 1203. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  129. Li, N.; Ma, W.-T.; Pang, M.; Fan, Q.-L.; Hua, J.-L. The Commensal Microbiota and Viral Infection: A Comprehensive Review. Front. Immunol. 2019, 10, 1551. [Google Scholar] [CrossRef] [PubMed]
  130. Byrd, A.L.; Belkaid, Y.; Segre, J.A. The human skin microbiome. Nat. Rev. Microbiol. 2018, 16, 143–155. [Google Scholar] [CrossRef]
  131. Grice, E.A.; Segre, J.A. The skin microbiome. Nat. Rev. Microbiol. 2011, 9, 244–253. [Google Scholar] [CrossRef]
  132. Flowers, L.; Grice, E.A. The Skin Microbiota: Balancing Risk and Reward. Cell Host Microbe 2020, 28, 190–200. [Google Scholar] [CrossRef]
  133. Pullerits, K.; Ahlinder, J.; Holmer, L.; Salomonsson, E.; Öhrman, C.; Jacobsson, K.; Dryselius, R.; Forsman, M.; Paul, C.J.; Rådström, P. Impact of UV irradiation at full scale on bacterial communities in drinking water. npj Clean Water 2020, 3, 11. [Google Scholar] [CrossRef] [Green Version]
  134. Hannigan, G.D.; Meisel, J.S.; Tyldsley, A.S.; Zheng, Q.; Hodkinson, B.P.; SanMiguel, A.J.; Minot, S.; Bushman, F.D.; Grice, E.A. The Human Skin Double-Stranded DNA Virome: Topographical and Temporal Diversity, Genetic Enrichment, and Dynamic Associations with the Host Microbiome. mBio 2015, 6, e01578-15. [Google Scholar] [CrossRef] [Green Version]
  135. Fukui, T.; Niikura, T.; Oda, T.; Kumabe, Y.; Ohashi, H.; Sasaki, M.; Igarashi, T.; Kunisada, M.; Yamano, N.; Oe, K.; et al. Exploratory clinical trial on the safety and bactericidal effect of 222-nm ultraviolet C irradiation in healthy humans. PLoS ONE 2020, 15, e0235948. [Google Scholar] [CrossRef]
  136. Yamano, N.; Kunisada, M.; Kaidzu, S.; Sugihara, K.; Nishiaki-Sawada, A.; Ohashi, H.; Yoshioka, A.; Igarashi, T.; Ohira, A.; Tanito, M.; et al. Long-term Effects of 222-nm ultraviolet radiation C Sterilizing Lamps on Mice Susceptible to Ultraviolet Radiation. Photochem. Photobiol. 2020, 96, 853–862. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  137. Kaidzu, S.; Sugihara, K.; Sasaki, M.; Nishiaki, A.; Igarashi, T.; Tanito, M. Evaluation of acute corneal damage induced by 222-nm and 254-nm ultraviolet light in Sprague–Dawley rats. Free Radic. Res. 2019, 53, 611–617. [Google Scholar] [CrossRef] [PubMed]
  138. Kaidzu, S.; Sugihara, K.; Sasaki, M.; Nishiaki, A.; Ohashi, H.; Igarashi, T.; Tanito, M. Re-Evaluation of Rat Corneal Damage by Short-Wavelength UV Revealed Extremely Less Hazardous Property of Far-UV-C. Photochem. Photobiol. 2021, 97, 505–516. [Google Scholar] [CrossRef] [PubMed]
  139. Sliney, D.H.; Stuck, B.E. A Need to Revise Human Exposure Limits for Ultraviolet UV-C Radiation. Photochem. Photobiol. 2021, 97, 485–492. [Google Scholar] [CrossRef]
  140. Tett, A.; Pasolli, E.; Farina, S.; Truong, D.T.; Asnicar, F.; Zolfo, M.; Beghini, F.; Armanini, F.; Jousson, O.; De Sanctis, V.; et al. Unexplored diversity and strain-level structure of the skin microbiome associated with psoriasis. npj Biofilms Microbiomes 2017, 3, 1–12. [Google Scholar] [CrossRef]
  141. Neu, D.T.; Mead, K.R.; McClelland, T.L.; Lindsley, W.G.; Martin, S.B.; Heil, G.; See, M.; Feng, H.A. Surface Dosimetry of Ultraviolet Germicidal Irradiation Using a Colorimetric Technique. Ann. Work Expo. Health 2021, 65, 605–611. [Google Scholar] [CrossRef]
  142. Mamahlodi, M.T. Potential benefits and harms of the use of UV radiation in transmission of tuberculosis in South African health facilities. J. Public Health Afr. 2019, 10, 742. [Google Scholar] [CrossRef]
  143. Moon, Y.; Han, S.; Son, J.W.; Park, S.H.; Ha, S.-D. Impact of ultraviolet-C and peroxyacetic acid against murine norovirus on stainless steel and lettuce. Food Control 2021, 130, 108378. [Google Scholar] [CrossRef]
  144. Jean, J.; Morales-Rayas, R.; Anoman, M.-N.; Lamhoujeb, S. Inactivation of hepatitis A virus and norovirus surrogate in suspension and on food-contact surfaces using pulsed UV light (pulsed light inactivation of food-borne viruses). Food Microbiol. 2011, 28, 568–572. [Google Scholar] [CrossRef]
  145. Li, D.; Baert, L.; De Jonghe, M.; Van Coillie, E.; Ryckeboer, J.; Devlieghere, F.; Uyttendaele, M. Inactivation of Murine Norovirus 1, Coliphage φX174, and Bacillus fragilis Phage B40-8 on Surfaces and Fresh-Cut Iceberg Lettuce by Hydrogen Peroxide and UV Light. Appl. Environ. Microbiol. 2011, 77, 1399–1404. [Google Scholar] [CrossRef] [Green Version]
  146. Ortiz-Solà, J.; Abadias, I.; Colàs-Medà, P.; Anguera, M.; Viñas, I. Inactivation of Salmonella enterica, Listeria monocytogenes and murine norovirus (MNV-1) on fresh strawberries by conventional and water-assisted ultraviolet light (UV-C). Postharvest Biol. Technol. 2021, 174, 111447. [Google Scholar] [CrossRef]
  147. Kato, T.; Tohma, H.; Miki, O.; Shibata, T.; Tamura, M. Degradation of Norovirus in Sewage Treatment Water by Photocatalytic Ultraviolet Disinfection. Nippon. Steel Tech. Rep. 2005, 92, 41–44. [Google Scholar]
  148. Barrett, M.; Fitzhenry, K.; O’Flaherty, V.; Dore, W.; Keaveney, S.; Cormican, M.; Rowan, N.; Clifford, E. Detection, fate and inactivation of pathogenic norovirus employing settlement and UV treatment in wastewater treatment facilities. Sci. Total Environ. 2016, 568, 1026–1036. [Google Scholar] [CrossRef] [PubMed]
  149. Garcia, L.A.T.; Nascimento, M.A.; Barardi, C.R.M. Effect of UV Light on the Inactivation of Recombinant Human Adenovirus and Murine Norovirus Seeded in Seawater in Shellfish Depuration Tanks. Food Environ. Virol. 2015, 7, 67–75. [Google Scholar] [CrossRef]
  150. Watts, M.J.; Linden, K.G. Chlorine photolysis and subsequent OH radical production during UV treatment of chlorinated water. Water Res. 2007, 41, 2871–2878. [Google Scholar] [CrossRef]
  151. Julius, A.A.; Sawyer, S.M. Control Systems Challenges in Energy Efficient Portable UV Based Water Sterilizer. In Proceedings of the 2010 American Control Conference, Baltimore, MD, USA, 30 July 2010; pp. 3617–3622. [Google Scholar]
  152. Alcala, J.R.; Gratton, E.; Prendergast, F.G. Fluorescence lifetime distributions in proteins. Biophys. J. 1987, 51, 597–604. [Google Scholar] [CrossRef] [Green Version]
  153. Bouchard, A.; Vernon, M.; Cormier, J.-F.; Beaulieu, R.; Mafu, A.A.; Fréchette, J.; Vallée, R. Optical characterization of Pseudomonas fluorescens on meat surfaces using time-resolved fluorescence. J. Biomed. Opt. 2006, 11, 1–7. [Google Scholar] [CrossRef]
  154. Whitham, T.; Saba, N.; Woo, H.; Carlson, K.; Bokzek, L.; Ryu, H. Efficacy of Inactivation of Pseudomonas aeruginosa by Multiple-Wavelength UV LEDs. Available online: https://cfpub.epa.gov/si/si_public_file_download.cfm?p_download_id=536619&Lab=NRMRL (accessed on 29 November 2021).
  155. ASHRAE Ultraviolet Lamp Systems. Available online: https://www.ashrae.org/file%20library/technical%20resources/covid-19/i-p_s16_ch17.pdf (accessed on 29 November 2021).
  156. Shimoda, H.; Matsuda, J.; Iwasaki, T.; Hayasaka, D. Efficacy of 265-nm ultraviolet light in inactivating infectious SARS-CoV-2. J. Photochem. Photobiol. 2021, 7, 100050. [Google Scholar] [CrossRef]
Figure 1. Phylogenetic diversity of HuNoV GII.2 strains based on major capsid protein VP1 depicting lineages in genogroups. Inner circle shows geographic location, while outer cycle shows phylogenetic clusters. Maximum likelihood was used to infer phylogeny using 519 VP1 gene sequences. List of GenBank accession numbers have been provided in supplementary Table S1 of Li et al. [5]. Figure reused from Li et al. [5] under Creative Commons CC BY license http://creativecommons.org/publicdomain/zero/1.0/ (accessed on 11 January 2022).
Figure 1. Phylogenetic diversity of HuNoV GII.2 strains based on major capsid protein VP1 depicting lineages in genogroups. Inner circle shows geographic location, while outer cycle shows phylogenetic clusters. Maximum likelihood was used to infer phylogeny using 519 VP1 gene sequences. List of GenBank accession numbers have been provided in supplementary Table S1 of Li et al. [5]. Figure reused from Li et al. [5] under Creative Commons CC BY license http://creativecommons.org/publicdomain/zero/1.0/ (accessed on 11 January 2022).
Pathogens 11 00226 g001
Table 1. Comparison of some human norovirus (HuNoV) model organisms (surrogates).
Table 1. Comparison of some human norovirus (HuNoV) model organisms (surrogates).
SurrogateAdvantagesDisadvantagesSource
Feline calicivirus (FCV)
Cultivable
Stable at some temperatures
Frequently used as surrogate in chemical disinfection and irradiation studies
Like HuNoVs, found to remain infective beyond 70 days on stainless steel and plastic at room temperature
RT-PCR results indicate FCV is easier to inactivate (e.g compared to MNV and MS2) and should be used as surrogate with caution
Sensitive to low pH unlike HuNoVs
Sensitive to drying
Different transmission route (FCV is a respiratory and not an enteric virus link HuNoV)
High infectivity-reduction rate
[49,65,66,67,68,69,70,71,72,73,74]
Murine norovirus (MN)
Cultivable
Stable across the a wide pH range.
Genetic similarity and environmental stability comparable to HuNoVs
Commonly used as surrogate in chemical disinfection and irradiation studies
Like HuNoVs, found to remain infective beyond 70 days on stainless steel and plastic at room temperature
Conservative HuNoV surrogate for UV disinfection
Sensitive to drying
Different UVC susceptibility to other surrogates
MNV environmental stability is different to HuNoV
[57,65,66,68,69,70,75,76]
Tulane virus (TV)
Cultivable
The biological features of recovirus closely reflect HuNoVs
Clinical manifestations and disease progression in infected mammalian organisms reflect human norovirus
Truly intestinal pathogen, also from Caliciviridae family like HuNoV
Recognizes the same ligand as HuNoVs
More resistant at low pH than FCV
Difficult to produce a high-titer stock via tissue culture
Reduction of virus titer at pH 2.5 and 9.0
[21,69,77,78]
Echovirus 12
Cultivable
Conservative HuNoV surrogate for UV disinfection
Shares morphological similarities with HuNoVs
Environmental persistence
Poses lower human health risks
This is a BSL-2 organism and may not be used widely.
Long incubation period (2–5 days)
[79,80,81]
MS2 and Qβ
Cultivable to high titers
BSL-1 organisms (non-pathogenic), thus possibility of widespread use
Potential surrogate for noroviruses on fresh produce with prolonged survival periods, both in buffer and on fresh produce, at temperatures relevant to chilled foods.
Conservative disinfection performance due to high UVC sensitivity than most pathogenic viruses
Sensitive in acidic environments
UVC resistance may lead to resource wasting, as it is too conservative.
[71,82,83,84]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Mariita, R.M.; Davis, J.H.; Randive, R.V. Illuminating Human Norovirus: A Perspective on Disinfection of Water and Surfaces Using UVC, Norovirus Model Organisms, and Radiation Safety Considerations. Pathogens 2022, 11, 226. https://doi.org/10.3390/pathogens11020226

AMA Style

Mariita RM, Davis JH, Randive RV. Illuminating Human Norovirus: A Perspective on Disinfection of Water and Surfaces Using UVC, Norovirus Model Organisms, and Radiation Safety Considerations. Pathogens. 2022; 11(2):226. https://doi.org/10.3390/pathogens11020226

Chicago/Turabian Style

Mariita, Richard M., James H. Davis, and Rajul V. Randive. 2022. "Illuminating Human Norovirus: A Perspective on Disinfection of Water and Surfaces Using UVC, Norovirus Model Organisms, and Radiation Safety Considerations" Pathogens 11, no. 2: 226. https://doi.org/10.3390/pathogens11020226

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop